Agios Pharmaceuticals-Agios Pharma reports mixed results in late-stage study for sickle cell disease drug

Agios Pharma reports mixed results in late-stage study for sickle cell disease drug

Agios Pharmaceuticals(US:AGIO) Reuters·2025-11-19 21:24

Agios Pharmaceuticals said on Wednesday its sickle cell drug met one of its two main goals in a late-stage study of patients aged 16 and older, but failed to show a statistically significant reduction... ...